novo nordisk glp-1 products promotes new receptor agonist to fight diabetes, obesity < Pharma < Article Novo's Wegovy becomes first GLP-1

While using Ozempic, your doctor may monitor certain health markers by taking blood or urine samples for lab testing

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that mimic a natural hormone involved in blood sugar regulation and appetite control

Kidney damage including kidney failure

The blood sugar level readings are then shown on a connecting device, such as a receiver, insulin pump or on an app on a phone

A coached, full-body strength workout with moderate effort, simple movement patterns, and room to adjust in real time

Tirzepatide (Mounjaro and Zepbound) - Tirzepatide is a dual-action therapy that targets GLP-1 and GIP (glucose-dependent insulinotropic peptide) receptors for enhanced weight loss benefits